Valuation: PuraPharm Corporation Limited

Market Cap 131M 16.64M 14.51M 13.7M 12.44M 23.31M 1.6B 23.41M 164M 63.33M 812M 62.51M 61.12M 2.61B P/E 2024
-6.13x
P/E 2025 -4.22x
Enterprise Value 446M 56.82M 49.55M 46.78M 42.48M 79.6M 5.45B 79.93M 560M 216M 2.77B 213M 209M 8.92B EV / Sales 2024
1.42x
EV / Sales 2025 1.5x
Free-Float
34.74%
Yield 2024 *
-
Yield 2025 -
1 day-2.40%
1 week-6.15%
Current month-11.27%
1 month-12.86%
3 months-20.00%
6 months-22.54%
Current year-31.27%
1 week 0.23
Extreme 0.23
0.28
1 month 0.23
Extreme 0.23
0.28
Current year 0.23
Extreme 0.23
0.38
1 year 0.23
Extreme 0.23
0.46
3 years 0.23
Extreme 0.23
1.23
5 years 0.23
Extreme 0.23
2
10 years 0.23
Extreme 0.23
4.39
Manager TitleAgeSince
Chief Executive Officer 65 1998-05-04
Director of Finance/CFO 38 2023-12-31
Investor Relations Contact - -
Director TitleAgeSince
Chairman 65 1998-05-04
Director/Board Member 60 2011-12-01
Director/Board Member 72 2015-06-11
Date Insider Type Main position Quantity % Market Cap. Importance
7/27/22 Other

Chief Executive Officer

30,000 0.0076%
7/27/22 Other 30,000 0.0076%
5/3/22 Other

Chief Executive Officer

77,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-2.40%-6.15%-45.78%-76.31% 16.64M
-0.66%+1.29%-12.72%-4.99% 13.59B
0.00%-0.77%-33.62%-57.02% 4.75B
-0.68%-1.27%-4.78%-8.58% 4.31B
+0.53%+0.07%-8.05%-32.68% 3.79B
+0.16%+1.57%-1.22%-4.44% 3.46B
+1.38%-0.06%-21.96%-0.83% 3.44B
-0.57%-1.14%-11.89%-1.35% 3.09B
-0.62%+0.48%-24.68%-19.05% 2.25B
+0.52%+0.16%-28.42%-23.68% 1.64B
Average -0.23%-1.36%-19.31%-22.89% 4.03B
Weighted average by Cap. -0.17%-0.59%-14.95%-15.00%

Financials

2024 2025
Net sales 382M 48.7M 42.47M 40.1M 36.41M 68.22M 4.67B 68.51M 480M 185M 2.38B 183M 179M 7.64B 336M 42.84M 37.36M 35.27M 32.03M 60.01M 4.11B 60.26M 423M 163M 2.09B 161M 157M 6.72B
Net income -35.44M -4.52M -3.94M -3.72M -3.38M -6.33M -433M -6.35M -44.55M -17.19M -220M -16.97M -16.59M -709M -35.22M -4.49M -3.91M -3.7M -3.36M -6.29M -431M -6.32M -44.28M -17.09M -219M -16.86M -16.49M -705M
Net Debt 327M 41.66M 36.33M 34.3M 31.15M 58.36M 4B 58.6M 411M 159M 2.03B 156M 153M 6.54B 315M 40.18M 35.04M 33.08M 30.04M 56.29M 3.86B 56.52M 396M 153M 1.96B 151M 148M 6.31B
Logo PuraPharm Corporation Limited
PuraPharm Corporation Ltd is an investment holding company principally engaged in the concentrated Chinese medicine granule (CCMG) businesses. The Company operates through five business segments. The China CCMG segment is mainly engaged in the production and sales of CCMG products in China. The Hong Kong CCMG segment is mainly engaged in the sales of CCMG products, excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment is mainly engaged in the production and sales of healthcare products in Hong Kong and China. The Clinics segment is mainly engaged in the provision of Chinese medical diagnostic services and sales of CCMG products through self-operated clinics. The Plantation segment is mainly engaged in the plantation and trading of raw Chinese herbs, and the manufacture and sale of traditional Chinese medicine (TCM) decoction pieces.
Employees
460
Date Price Change Volume
26-09-18 HK$0.2440 -2.40% 220,750
26-09-17 HK$0.2500 -9.09% 4,500
26-09-16 HK$0.2750 +1.85% 7,000
26-09-15 HK$0.2700 0.00% 0
26-09-14 HK$0.2700 +3.85% 360,500

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1498 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!